PUBLIC RELEASE DATE: <\/p>\n
8-Dec-2014 <\/p>\n
Contact: Kat J. McAlpine katherine.mcalpine@wyss.harvard.edu<\/a> 617-432-8266 Wyss Institute for Biologically Inspired Engineering at Harvard @wyssinstitute<\/p>\n (BOSTON and CAMBRIDGE, Massachusetts) - One of the reasons cancer is so deadly is that it can evade attack from the body's immune system, which allows tumors to flourish and spread. Scientists can try to induce the immune system, known as immunotherapy, to go into attack mode to fight cancer and to build long lasting immune resistance to cancer cells. Now, researchers at the Wyss Institute for Biologically Inspired Engineering and Harvard's School of Engineering and Applied Sciences (SEAS) show a non-surgical injection of programmable biomaterial that spontaneously assembles in vivo into a 3D structure could fight and even help prevent cancer and also infectious disease such as HIV. Their findings are reported in Nature Biotechnology. <\/p>\n \"We can create 3D structures using minimally invasive delivery to enrich and activate a host's immune cells to target and attack harmful cells in vivo,\" said the study's senior author David Mooney, Ph.D., who is a Wyss Institute Core Faculty Member and the Robert P. Pinkas Family Professor of Bioengineering at Harvard SEAS . <\/p>\n Tiny biodegradable rod-like structures made from silica, known as mesoporous silica rods (MSRs), can be loaded with biological and chemical drug components and then delivered by needle just underneath the skin. The rods spontaneously assemble at the vaccination site to form a three-dimensional scaffold, like pouring a box of matchsticks into a pile on a table. The porous spaces in the stack of MSRs are large enough to recruit and fill up with dendritic cells, which are \"surveillance\" cells that monitor the body and trigger an immune response when a harmful presence is detected. <\/p>\n \"Nano-sized mesoporous silica particles have already been established as useful for manipulating individual cells from the inside, but this is the first time that larger particles, in the micron-sized range, are used to create a 3D in vivo scaffold that can recruit and attract tens of millions of immune cells,\" said co-lead author Jaeyun Kim, Ph.D., an Assistant Professor of Chemical Engineering at Sungkyunkwan University and a former Wyss Institute Postdoctoral Fellow. <\/p>\n Synthesized in the lab, the MSRs are built with small holes, known as nanopores, inside. The nanopores can be filled with specific cytokines, oligonucleotides, large protein antigens, or any variety of drugs of interest to allow a vast number of possible combinations to treat a range of infections. <\/p>\n \"Although right now we are focusing on developing a cancer vaccine, in the future we could be able to manipulate which type of dendritic cells or other types of immune cells are recruited to the 3D scaffold by using different kinds of cytokines released from the MSRs,\" said co-lead author Aileen Li, a graduate student pursuing her Ph.D. in bioengineering at Harvard SEAS. \"By tuning the surface properties and pore size of the MSRs, and therefore controlling the introduction and release of various proteins and drugs, we can manipulate the immune system to treat multiple diseases.\" <\/p>\n Once the 3D scaffold has recruited dendritic cells from the body, the drugs contained in the MSRs are released, which trips their \"surveillance\" trigger and initiates an immune response. The activated dendritic cells leave the scaffold and travel to the lymph nodes, where they raise alarm and direct the body's immune system to attack specific cells, such as cancerous cells. At the site of the injection, the MSRs biodegrade and dissolve naturally within a few months. <\/p>\n <\/p>\n Originally posted here: <\/p>\n Injectable 3-D vaccines could fight cancer and infectious diseases<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" PUBLIC RELEASE DATE: 8-Dec-2014 Contact: Kat J. McAlpine katherine.mcalpine@wyss.harvard.edu<\/a> 617-432-8266 Wyss Institute for Biologically Inspired Engineering at Harvard @wyssinstitute (BOSTON and CAMBRIDGE, Massachusetts) - One of the reasons cancer is so deadly is that it can evade attack from the body's immune system, which allows tumors to flourish and spread. Continue reading